MedPath

A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition

Phase 2
Completed
Conditions
Anorexia
Cachexia
HIV Infections
Registration Number
NCT00002300
Lead Sponsor
Bristol-Myers Squibb
Brief Summary

To compare the effects of megestrol acetate and placebo on body weight, anorexia, cachexia, calorie intake, and nutritional parameters of patients with a confirmed diagnosis of AIDS. To characterize dose response in relation to weight gain. To determine whether megestrol acetate relative to placebo improves the perception of well-being among AIDS patients with cachexia. To evaluate megestrol acetate's effect on immune function via skin test reactivity, T4/T8 ratio, and total lymphocytes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (15)

Birmingham Veterans Administration Med Ctr / Univ of Alabama

🇺🇸

Birmingham, Alabama, United States

Dr NS Tchekmedyian

🇺🇸

Long Beach, California, United States

Dr Stephen J Gabin Jr

🇺🇸

Los Angeles, California, United States

Eisenhower Med Ctr

🇺🇸

Rancho Mirage, California, United States

Denver Public Health Dept

🇺🇸

Denver, Colorado, United States

George Washington Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

Veterans Administration Med Ctr

🇺🇸

Washington, District of Columbia, United States

Miami Veterans Administration Med Ctr

🇺🇸

Miami, Florida, United States

Northwestern Univ Med School

🇺🇸

Chicago, Illinois, United States

Albany Med College / AIDS Treatment Ctr

🇺🇸

Albany, New York, United States

Scroll for more (5 remaining)
Birmingham Veterans Administration Med Ctr / Univ of Alabama
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.